SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0000318306-01-500002
Filing Date
2001-01-16
Accepted
2001-01-16 00:00:00
Documents
5

Document Format Files

Seq Description Document Type Size
1 S-3/A DOCUMENT r116a.txt S-3/A 65167
2 OPINION BINGHAM DANA LLP r116b.txt EX-5.1 2912
3 CONSENT GRANT THORNTON LLP r116c.txt EX-23.2 742
4 CONSENT KPMG LLP r116d.txt EX-23.3 808
5 CONSENT SMITH ANGLIN r116e.txt EX-23.4 420
  Complete submission text file 0000318306-01-500002.txt   72146
Mailing Address 2600 N STEMMONS FRWY STE 210 DALLAS TX 75207
Business Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207 2149055100
ACCESS PHARMACEUTICALS INC (Filer) CIK: 0000318306 (see all company filings)

IRS No.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3/A | Act: 33 | File No.: 333-52030 | Film No.: 1509496
SIC: 2834 Pharmaceutical Preparations